Here’s what you should know:
1. Henry Schein’s sales increased 10.3 percent, year-over-year.
2. Henry Schein reported net income of $138 million for the third quarter, which was up 3.2 percent from the same period last year.
3. The company’s medical division saw $690.8 million in sales, which was an 8 percent increase year-over-year. Henry Schein’s dental division was still its most profitable with sales of $1.5 billion in the third quarter.
4. Henry Schein’s CEO Stanley Bergman said in a release, “Solid overall sales results for the quarter reflect continued success with our comprehensive offering of products and value-added services that drive internal growth, complemented by strategic acquisitions.”
5. Through the first three quarters of 2017, Henry Schein posted $9.1 billion in sales. Concerning end-of-year outlooks, Henry Schein expects to post earnings between $3.46 and $3.48 earnings per share.
More articles on transactions/valuations:
Wilford Eye Center unites eye surgery departments — 4 insights
6 recent ASC acquisitions & partnerships — October 2017
3 trends gaining traction in ASC valuations heading into 2018
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.